Medtronic to Buy Contego Medical for $380 Million, Days After FDA Approves Its Carotid System
Medtronic plans to buy Contego Medical for $380 million plus undisclosed contingent payments. The deal adds a carotid stenting system with a built-in filter that the FDA approved days earlier, setting up direct competition with Boston Scientific in the growing field of transcarotid revascularization.
FDA Clears Insera’s CLEAR Aspiration System, Which Pulses Suction to Remove Peripheral Clots
Insera Therapeutics has FDA 510(k) clearance for a thrombectomy system that pulses suction instead of holding it steady. The clearance covers peripheral arteries and veins and rests on bench and animal testing. No clinical outcome data were submitted, and no US launch date has been announced.